Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy(426 views) Ribaldone DG, Dileo I, Pellicano R, Resegotti A, Fagoonee S, Vernero M, Saracco G, Astegiano M
Gastroenterology-U, General and Specialist Medicine Department, Citta della Salute e della Scienza of Turin, C.so Bramante 88, 10126, Turin, Italy. davrib_1998@yahoo.com., Department of Gastroenterology and Hepatology, Molinette Hospital-S.G.A.S, Via Cavour 31, 10123, Turin, Italy. davrib_1998@yahoo.com., Unit of Gastroenterology and Hepatology, Molinette Hospital, 10126, Turin, Italy., Fourth General Surgery Department, Citta della Salute e della Scienza, Azienda Ospedaliera ed Universitaria, 10126, Turin, Italy., Institute for Biostructures and Bioimages-CNR c/o Molecular Biotechnology Center, University of Torino, 10126, Turin, Italy., Department of Medical Sciences, University of Torino, 10126, Turin, Italy.,
References: Not available.
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy
BACKGROUND: There is no agreeing if rescue therapy can avoid short-term colectomy in patients treated for severe steroid-refractory ulcerative colitis. AIMS: The aim of our study was to identify predictors of response to infliximab and cyclosporine A. METHODS: In this cross-sectional study, 49 patients with severe ulcerative colitis were included. Response to therapy was defined as three or more point reductions in Mayo score after 6 months of treatment and avoidance of colectomy after 1 year. The predictors analysed were gender, age, time from ulcerative colitis diagnosis, months of steroid or/and azathioprine therapy before onset of the severe phase, smoking habits, extension of the disease, laboratory analyses and Mayo score. RESULTS: Patients treated with infliximab showed a statistically significant higher response rate in case of moderate Mayo score (P = 0.04). Ex-smokers had very low chance of response to infliximab (P = 0.03). In the group treated with cyclosporine A, patients with C-reactive protein >3 mg/L had a response rate significantly higher than those with C-reactive protein <3 mg/L (P = 0.03); those with negative C-reactive protein and moderate Mayo score did not responded to therapy, while in the ones with elevated C-reactive protein and/or severe Mayo score, 15 versus 4 responded (P = 0.008). CONCLUSIONS: Our data suggest that cyclosporine A is advisable in ex-smokers. In never smokers or active smokers, infliximab can be prescribed in case of Mayo score 10 and positive CRP.
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy
No results.
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy